期刊文献+

新疆维族妇女宫颈鳞癌中hTERT p33^(ING1)的相关性探讨 被引量:1

The Expression of p33ING1 and hTERT in cervical cancer in Uygur females in XinJiang
下载PDF
导出
摘要 目的:探讨p33ING1和hTERT在新疆维族妇女宫颈鳞癌组织中的表达及其相互关系。方法:用免疫组化法检测SCC52例,CIN、CIS35例患者中p33ING1和hTERT表达,并用正常宫颈13例作为对照。结果:1)对照组、CINⅠ+Ⅱ级组、CINⅢ级+CIS组、SCC组p33ING1阳性率分别为84.6%、90.0%、64.0%、19.2%,SCC组阳性表达减少,与前三组有显著性差异(P<0.05);2)四组hTERT阳性率分别为15.4%、70.0%、96.0%、100%,SCC组阳性表达率明显增加,各组比较之间有统计学意义(P<0.05);3)宫颈组织中p33ING1和hTERT阳性表达呈负相关(P<0.05)。结论:新疆维族妇女宫颈癌组织中p33ING1表达减少,而hTERT表达增加,同时检测它们的表达,有助于宫颈癌的早期诊断。 Objective: To study the clinical significance of p33ING1 and hTERT protein expression in cervical squamous carcinoma from Uygur females in XinJiang. Methods: Using immunohistochemical staining, the expression level of p33ING1 and hTERT was examined in 52 cases of cervical cancer, 35 cases of cervical intraepithelial neoplasia (CIN) and cancer in situ, and 13 control cases. Results: 1) p33ING1 expression in the control group, the CINⅠ-Ⅱ group, the CINⅢ/CIS group and the SCC group was 84.6%, 90.0%, 64.0%, and 19.2%, respectively. The p33ING1 expression in the SCC group was significantly lower than that in the other groups (P〈0.05). 2) hTERT expression in the control group, the CINⅠ-Ⅱ group, the CINⅢ/CIS group and the SCC group was 15.4%, 70.0%, 96.0%, and 100%, respectively. The expression of hTERT in the SCC group was significantly higher than that in the. other groups (/9〈0.05); 3) The expression of p33ING1 is correlated with that of hTERT in cervical tissue , but their expression is not related to tumor differentiation. Conclusion: The expression of p33ING1 in cervical carcinoma is low and the expression of hTERT is high. Detection of p33ING1 and hTERT protein expression may help with early diagnosis of cervical carcinoma in Uygur females in XinJiang.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2007年第12期680-682,共3页 Chinese Journal of Clinical Oncology
基金 新疆维吾尔自治区自然科学基金资助(编号:200521107)
关键词 宫颈鳞癌 P33ING1 HTERT 免疫组化 维族妇女 cervical squamous carcinoma p33ING1 hTERT Uygur female immunohistochemistry
  • 相关文献

参考文献11

  • 1Garkavtsev I,Kazarov A,Gudkov A,et al.Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation[J].Nat Genet,1996,14(4):415~420
  • 2Nouman GS,Anderson JJ,Crosier S,et al.Downregulation of nuclear expression of the p33ING1b inhibitor of growth protein in invasive carcinoma of the breast[J].J Clin Pathol,2003,56(7):507~511
  • 3Chen L,Matsubara N,Yoshino T,et al.Genetic alterations of candidate trunor suppressor ING1 in human esophageal squamous cell cancer[J].Cancer Res,2001,61(11):4345~4349
  • 4任琛琛,王鲁文,李靖若.宫颈癌组织抑癌基因P^(33ING1)及P^(53)表达的临床意义[J].第四军医大学学报,2005,26(18):1683-1684. 被引量:3
  • 5Widschwendter A,Muller HM,Hubalek MM,et al.Methylation status and expression of human telomerase rcverse transcriptase in ovarian and cervical cancer[J].Gynecol Oncol,2004,93(2):407~416
  • 6Tchirkov A,Chaleteix C,Magnac C,et al.hTERT expression and prognosis in B-chronic lymphocytic leukemia[J].Ann Oncol,2004,15(10):1476~1480
  • 7卢山珊,王群姬,吴秀玲.免疫组化检测端粒酶活性和p53在宫颈上皮内瘤变及宫颈癌中的表达[J].温州医学院学报,2004,34(6):441-443. 被引量:2
  • 8Leung KM,Po LS,Tsang FC,et al.The candidate tumor suppressor ING1b can stabilize p53 by disrupting the regulation of p53 by MDM2[J].Cancer Res,2002,62(17):4890~4893
  • 9Tokunaga E,Maehara Y,Oki E,et al.Diminished expression of ING1 mRNA and the correlation with p53 expression in breast cancers[J].Cancer Lett,2000,152(1):15~22
  • 10Shinoura N,Muramatsu Y,Nishimura M,et al.Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas[J].Cancer Res,1999,59(21):5521~5528

二级参考文献14

  • 1Noman GS, Anderson JJ, Lanec J, et al. The role of the tumer suppresor in human noeplasia [J]. J Clin Pathol, 2003;56(7):491.
  • 2Cheung KJ Jr, Li G. The Tumer Suppressor ING1: Structure and function [J]. Exp Cell Res, 2001;268(1):1.
  • 3Cheng KJ Jr, Mitchell D. Lin P. et al. The tumor suppressor candidate P33ING1 mediates repair of UV-danaged DNA [J].Cancer Res, 2001;61:4974-4977.
  • 4Nouman GS, Anderson JJ, Crosier S. Downregulation of nuclear expression of the P33ING1 inhibitor of growth protein in invasive carcinoma of the breast [J].J Clin Pathol, 2003;56(7):507.
  • 5Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer [J]. Science, 1994,266(2):2011-2014.
  • 6Villa K, Folini M, Porta CD, et al. Inhibition of telomerase activity by geldanamycin and 17-allyamino, 17-demethoxygeldanamycin in human melanoma cell[J]. Carcinogenesis, 2003, 24(5): 851-859.
  • 7Wallace MB, Block M, Hoffman BJ,et al. Detection of telomerase expression in mediastinal lymph nodes of patients with lung cancer[J]. Am J Respir Crit Care Med,2003,167(12): 1670-1675.
  • 8Sen S,Reddy VG, Guleria R, et al.Telomerase-a potential molecular marker of lung and cervical[J]. Clin Chen Lab Med,2002,40(10):994-1001.
  • 9Pao CC, Tseng CJ, Lin CY, et al. Differential expression of telomerase activity in human cervical cancer and cervical intraepithclial neoplasm lesions [J]. J Clinic Oncology,1997,15(5):1932-1939.
  • 10Bos AB, Van Ballegooijen M,Van Oortmarssen GJ, et al. Non-progression of cervical intraepithelial neoplasia estimated from population-screening date [J]. Br J Cancer,1997,75(1):124-130.

共引文献3

同被引文献18

  • 1任琛琛,王鲁文,李靖若.宫颈癌组织抑癌基因P^(33ING1)及P^(53)表达的临床意义[J].第四军医大学学报,2005,26(18):1683-1684. 被引量:3
  • 2陈小东,梁启廉,李建文,黄水传,黄冰,郑朝晖.乳腺癌中血管内皮生长因子和抑癌基因p33ING1的表达及意义[J].中华实验外科杂志,2007,24(1):18-19. 被引量:5
  • 3Garkavtsev I, Kazarov A, Gudkov A, et al. Suppression of the novel growth inhibitor p331NG1 promotes neoplastic transformation[J]. Nat Genet, 1996,14(4):415-420.
  • 4Oki E, Maehara Y, Tokunaga E, et al. Reduced expression of p33ING1 and the relationship with p53 expression in human gastric cancer[]]. Gancer Lett, 1999, 147(1-2): 157-162.
  • 5Goeman F, Otto K, Kyrylenko S, et al. ING2 recruits histonc methyltransferase activity with methylation site specificity distinct from histone H3 lysines 4 and 9[J]. Biochim Biophys Acta, 2008, 1783(10): 1673-1680.
  • 6Abad M, Menendez C, Fuchtbauer A, et al. Ingl mediates p53 accumulation and chromatin modification in response to oncogenic stress[J].J Biol Chem, 2007, 282(42): 31060-31067.
  • 7Soliman MA, Riabowol K. After a decade of studyiNG, a PHD for a versatile family of proteins[J]. Trends Biochem Sci, 2007, 32 (11): 509-519.
  • 8Russell MW, Soliman MA, Schriemer D, et al. ING1 protein targefing to the nudeus by karyopherins is necessary for activation of p21[J]. Biochem Biophys Res Commun, 2008, 374(3):490-495.
  • 9Garkavtsev I, Grigorian IA, Ossovskaya VS, et at. The candidate turnout suppressor p33ING1 cooperates with p53 in cen growth control[J].Nature, 1998, 391(6664): 295-298.
  • 10Gong W, Russell M, Suzuki K, et al. Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expressionS. Mol Cell Biol, 2006, 26(8): 2947-2954.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部